Загрузка...
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency
[Image: see text] Non-covalent inhibitors of the main protease (M(pro)) of SARS-CoV-2 having a pyridinone core were previously reported with IC(50) values as low as 0.018 μM for inhibition of enzymatic activity and EC(50) values as low as 0.8 μM for inhibition of viral replication in Vero E6 cells....
Сохранить в:
| Опубликовано в: : | ACS Med Chem Lett |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Chemical
Society
2021
|
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8291137/ https://ncbi.nlm.nih.gov/pubmed/34408808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.1c00326 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|